著者
大野 能之 樋坂 章博 岩本 卓也 木村 丈司 百 賢二 米澤 淳 伊藤 清美
出版者
一般社団法人日本医療薬学会
雑誌
医療薬学 (ISSN:1346342X)
巻号頁・発行日
vol.44, no.11, pp.537-545, 2018-11-10 (Released:2019-11-10)
参考文献数
11

The first academic subcommittee of the Japanese Society of Pharmaceutical Health Care and Sciences has a plan to create a guide on how to manage drug interactions in clinical settings. This review describes the information that forms the basis of the guide. This article, part (1), reports the results of a questionnaire on the content of the guide and also describes how to evaluate and manage drug interactions in clinical settings. The contents of the ʻDrug Interaction Guideline for Drug Development and Labeling Recommendationsʼ, the new Japanese guideline, are also described. It is important also in clinical practice to appropriately evaluate and manage drug interactions based on a sufficient understanding of the new guideline and related information.

言及状況

外部データベース (DOI)

Twitter (6 users, 6 posts, 10 favorites)

【#キク勉】おー。これは参考になりそう。1~3ある☺ J-STAGE Articles - 医療現場における薬物相互作用へのかかわり方(1) https://t.co/accW7ed4gg
J-STAGEで公開されましたね(要認証)。 医療現場における薬物相互作用へのかかわり方(1) https://t.co/vj3v1vOiY8

収集済み URL リスト